BOURGEON CAPITAL MANAGEMENT LLC
Position in TEVA — Teva Pharmaceutical Industries Ltd
CIK 1088731
Darien, CT
Position in TEVA
as of Jun 30, 2026
· filed Jul 22, 2026
Position Value
$9,112,703
+$490,643 QoQ
Shares Held
268,970
-6.0% QoQ
Ownership
0.023%
of shares outstanding
% of Portfolio
1.44%
of 13F equity value
Holder Rank
#157
of 673 holders
Holding Since
Jun 2023
13 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in TEVA Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026BOURGEON CAPITAL MANAGEMENT LLC holds $9,112,703 across 1 Drug Manufacturers - Specialty & Generic name. TEVA ranks #1 (100.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TEVA |
Teva Pharmaceutical Industries Ltd
This page
|
268,970 | $9,112,703 |
All Filings in TEVA
Export CSV
13 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $9,112,703 | 268,970 | Shares | Sole | 2026-07-22 | |
| 2026-03-31 | $8,622,060 | 286,257 | Shares | Sole | 2026-04-13 | |
| 2025-12-31 | $19,080,077 | 611,345 | Shares | Sole | 2026-01-15 | |
| 2025-09-30 | $14,544,000 | 720,000 | Shares | Sole | 2025-10-21 | |
| 2025-06-30 | $12,133,804 | 723,974 | Shares | Sole | 2025-07-18 | |
| 2025-03-31 | $5,544,297 | 360,722 | Shares | Sole | 2025-04-09 | |
| 2024-12-31 | $14,545,408 | 659,955 | Shares | Sole | 2025-01-17 | |
| 2024-09-30 | $11,953,044 | 663,321 | Shares | Sole | 2024-10-16 | |
| 2024-06-30 | $10,860,460 | 668,336 | Shares | Sole | 2024-07-11 | |
| 2024-03-31 | $9,384,448 | 665,092 | Shares | Sole | 2024-04-19 | |
| 2023-12-31 | $6,876,253 | 658,645 | Shares | Sole | 2024-01-30 | |
| 2023-09-30 | $6,748,452 | 661,613 | Shares | Sole | 2023-11-01 | |
| 2023-06-30 | $4,907,752 | 651,760 | Shares | Sole | 2023-07-20 | |
| No filing history on record for this holder in this stock. | ||||||